Not exact matches
In 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cell
In 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study
in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cell
in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer
stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cell
in mice and
in lab cultures, and it also prevented the growth of new tumor cell
in lab cultures, and it also prevented the growth of new tumor
cells.
In collaboration with Ding, the lab of Olivier Voinnet at the Swiss Federal Institute of Technology in Zurich also reported in an accompanying paper the detection of viral siRNAs in cultured mouse embryonic stem cells infected by the Encephalomyocarditis viru
In collaboration with Ding, the
lab of Olivier Voinnet at the Swiss Federal Institute of Technology
in Zurich also reported in an accompanying paper the detection of viral siRNAs in cultured mouse embryonic stem cells infected by the Encephalomyocarditis viru
in Zurich also reported
in an accompanying paper the detection of viral siRNAs in cultured mouse embryonic stem cells infected by the Encephalomyocarditis viru
in an accompanying paper the detection of viral siRNAs
in cultured mouse embryonic stem cells infected by the Encephalomyocarditis viru
in cultured
mouse embryonic
stem cells infected by the Encephalomyocarditis virus.
Transplants grown from
stem cells in the
lab can help replenish the blood and have been used to cure anaemia
in mice.
Glioblastomas
in lab dishes and
mouse brains are fakes, little Potemkin villages that everyone thought were faithful replicas of human glioblastomas but which, lacking tumor
stem cells, were nothing of the kind.
Another is that the transplanted bits of tumor act nothing like cancers
in actual human brains, Fine and colleagues reported
in 2006: Real - life glioblastomas grow and spread and resist treatment because they contain what are called tumor
stem cells, but tumor
stem cells don't grow well
in the
lab, so they don't get transplanted into those
mouse brains.
In 2009, Hans Clevers of the Hubrecht Institute in Utrecht, the Netherlands, announced that his lab unexpectedly created a miniature version of a gut while cultivating adult stem cells that the team had discovered in mouse intestinal tissu
In 2009, Hans Clevers of the Hubrecht Institute
in Utrecht, the Netherlands, announced that his lab unexpectedly created a miniature version of a gut while cultivating adult stem cells that the team had discovered in mouse intestinal tissu
in Utrecht, the Netherlands, announced that his
lab unexpectedly created a miniature version of a gut while cultivating adult
stem cells that the team had discovered
in mouse intestinal tissu
in mouse intestinal tissue.
To find out if this was true, workers
in stem -
cell biologist Irving Weissman's
lab at Stanford University Medical School took one blood
stem cell from an adult
mouse and tagged it with a marker that glowed green under fluorescent light.
Ralph Brinster, part of the team at the University of Pennsylvania
in Philadelphia that first cultured sperm
stem cells in the
lab, has written that culturing
stem cells from human sperm is not far off — humans and
mice, like other mammals, he says, require similar growth factors.
Another
lab ran into a similar problem when it tried to replicate work by Stanford
stem cell biologist Irving Weissman and his colleagues, who reported
in 2012
in the Proceedings of the National Academy of Sciences that an antibody to a tumor
cell surface receptor called CD47 can slow tumor growth
in mice.
Lead researcher Christoph Lepper, a predoctoral fellow
in Carnegie's Chen - Ming Fan's
lab and a Johns Hopkins student, for the first time looked at these two genes
in promoting
stem cells at varying stages of muscle growth
in live
mice after birth.
Now, a new
STEM CELLS study from the labs of Qing - Ling Fu (Sun Yat - sen University, Guangzhou) and Zhongquan Qi (Xiamen University, Fujian, PR China) has described the effect of iPSC - MSCs on immune T cells in a relevant in vivo mouse m
CELLS study from the
labs of Qing - Ling Fu (Sun Yat - sen University, Guangzhou) and Zhongquan Qi (Xiamen University, Fujian, PR China) has described the effect of iPSC - MSCs on immune T
cells in a relevant in vivo mouse m
cells in a relevant
in vivo
mouse model.
The
mouse lines, which will be stored
in the form of frozen embryos, frozen sperm and frozen embryonic
stem (ES)
cells, will be delivered to NIH - funded
mouse repositories that supply
mice to universities, medical schools and research
labs all over the world.
In a series of lab experiments with cell lines, human xenograft tumors in mice and primary human prostate cancer samples, the researchers demonstrated that miR - 34a inhibits prostate cancer stem cells by suppressing CD4
In a series of
lab experiments with
cell lines, human xenograft tumors
in mice and primary human prostate cancer samples, the researchers demonstrated that miR - 34a inhibits prostate cancer stem cells by suppressing CD4
in mice and primary human prostate cancer samples, the researchers demonstrated that miR - 34a inhibits prostate cancer
stem cells by suppressing CD44.